Why the study?
Can multiple electrode platelet aggregometry (multiplate) detect platelet dysfunction in patients undergoing routine coronary artery surgery?
Can multiple electrode platelet aggregometry (multiplate) detect platelet dysfunction in patients undergoing routine coronary artery surgery?
Multiple electrode platelet aggregometry (multiplate) is a point-of-care analyzer capable of detecting platelet dysfunction during and after cardiopulmonary bypass in patients undergoing coronary artery surgery.
Answers are grounded in this paper and cite their sources.
Multiplate may detect transfusion-related platelet dysfunction in CABG; hypothesis-generating and should not yet change practice.
Platelet dysfunction after cardiopulmonary bypass contributes to microvascular bleeding and is associated with blood transfusion and resternotomy. Platelet count can be readily performed, but currently there are no standardised, reproducible, rapidly available platelet function tests. We studied platelet function as measured by multiple electrode platelet aggregometery (multiplate) and light transmission aggregometry in 44 patients undergoing routine coronary artery surgery. Platelet aggregation as measured by multiplate was reduced during and after cardiopulmonary bypass compared with baseline with evidence of partial recovery by the time of transfer to ITU. In patients transfused blood, platelet aggregation measured by multiplate was reduced during chest closure with adenosine diphosphate (18 U vs 29 U, p = 0.01) and thrombin receptor agonist peptide-6 agonist (65 U vs 88 U, p = 0.01) compared with patients not transfused. This suggests that multiplate, a new point of care analyser, can detect platelet dysfunction in this setting.
No takes yet. Share an insight, caveat, or question.
Reece et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: